<DOC>
	<DOCNO>NCT00830349</DOCNO>
	<brief_summary>The objective study compare rate extent absorption risperidone 1 mg tablet ( test ) versus Risperdal® ( reference ) administer 1 x 1 mg tablet fast condition .</brief_summary>
	<brief_title>Risperidone 1 mg Tablet Healthy Subjects Under Fasting Conditions</brief_title>
	<detailed_description>Criteria Evaluation : FDA Bioequivalence Criteria Statistical Methods : FDA bioequivalence statistical method</detailed_description>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Inclusion Criteria Subjects females and/or male , nonsmoker , 18 year age old . Subjects read , sign date Informed Consent Form prior study procedure . Female Subjects postmenopausal surgically sterilezed . Postmenopausal status define absence menses past 12 month , Sterile status define hysterectomy , bilateral oophorectomy tubal ligation least 6 month ago . Exclusion Criteria Subjects follow applies exclude study : Clinically significant illness within 4 week administration study medication . Clinically significant surgery within 4 week prior administration study medication . Any history presence significant Neurological , hepatic , renal , endocrine , cardiovascular , pulmonary , hematologic , immunologic , psychiatric metabolic disease . Any clinically significant abnormality find medical screening . Any reason , opinion medical subinvestigator , would prevent subject participate study . Abnormal laboratory test judge clinically significant . Subjects tolerate venipuncture . Positive urine drug screen screen . Subjects use tobacco form eligible participate study . Three month abstinence screening require . Positive test hepatitis B , hepatitis C HIV screen . ECG abnormality ( clinically significant ) ( PR interval great 225 msec QTc segment great 450 msec ) vital sign abnormality ( systolic blood pressure low 100 160 mmHg , diastolic blood pressure low 60 96 ; heart rate le 60 bpm ) screening . Subjects BMI ≥30.0 . History seizures predispose factor . History significant alcohol abuse within six month screen visit indication regular use two unit alcohol per day ( 1 Unit = 150 mL wine 360 mL beer 45 mL alcohol 40 % ) . History drug abuse use illegal drug : use soft drug ( marijuana , pot ) within 3 month screen visit hard drug ( cocaine , phencyclidine ( PCP ) crack ) within 1 year screen visit . History cardiac disease family history cardiac disease . Any food allergy , intolerance , restriction special diet , opinion medical subinvestigator , contraindicate subject 's participation study . History allergic reaction risperidone . Use drug know induce inhibit hepatic drug metabolism , use investigational drug participation investigation study within 30 day prior administration study medication . Use prescription medication within 14 day prior administration study medication overthecounter product within 7 day prior administration study medication , except topical product without systemic absorption . Donation plasma ( 500 mL ) within 7 day donation significant loss whole blood ( 500 mL ) within 56 day prior administration study medication . Positive alcohol breath test screening . Additional exclusion criterion female subject : Positive urine pregnancy test screening ( performed female ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Healthy Subjects</keyword>
</DOC>